» Articles » PMID: 34355011

Prognostic Value of Combined Preoperative Carcinoembryonic Antigen and Prognostic Nutritional Index in Patients With Stage II-III Colon Cancer

Overview
Journal Front Surg
Specialty General Surgery
Date 2021 Aug 6
PMID 34355011
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor status can affect patient prognosis. Prognostic nutritional index (PNI), as a nutritional indicator, is closely related to the prognosis of cancer. However, few studies have examined the combined prognostic value of CEA and PNI in patients. This study investigated the relationship between CEA/PNI and prognosis of colon cancer patients. A total of 513 patients with stage II-III colon cancer who underwent curative resection at two medical centers from 2009 to 2019 were included. Clinicopathological factors were assessed and overall survival (OS) was assessed in a cohort of 413 patients. Multivariate analysis was used to identify independent prognostic variables to construct histograms predicting 1-year and 3-year OS. Data from 100 independent patients in the validation group was used to validate the prognostic model. The median OS time was 33.6 months, and mortality was observed in 54 patients. Multivariate analysis revealed that preoperative CEA/PNI, lymph node metastasis, peripheral nerve invasion, operation mode, and postoperative chemotherapy were independent factors for prognosis evaluation and thus were utilized to develop the nomogram. The C-index was 0.788 in the learning set and 0.836 in the validation set. The calibration curves reached favorable consensus among the 1-, 3-year OS prediction and actual observation. The combined use of CEA and PNI is an independent prognostic factor and thus can serve as a basis for a model to predict the prognosis of patients with stage II-III colon cancer.

Citing Articles

Prognosis in stage II colon cancer: Expanding the horizons of risk factors.

Novoa Diaz M, Gentili C, Martin M, Carriere P World J Gastrointest Oncol. 2025; 17(2):100552.

PMID: 39958547 PMC: 11756003. DOI: 10.4251/wjgo.v17.i2.100552.


Combined preoperative prognostic nutritional index and D-dimer score predicts outcome in colorectal cancer.

Zhu S, Yin J, Ye Q, Xiang J, Zhang Z, Yan B BMC Surg. 2023; 23(1):30.

PMID: 36750842 PMC: 9903491. DOI: 10.1186/s12893-023-01925-8.


Preoperative Absolute Lymphocyte Count to Carcinoembryonic Antigen Ratio Is a Superior Predictor of Survival in Stage I to III Colorectal Cancer.

Zhou Y, Cheng F, Zhang Z, Xiang J, Xue T, Ye Q Clin Med Insights Oncol. 2022; 16:11795549221126249.

PMID: 36186673 PMC: 9515526. DOI: 10.1177/11795549221126249.


Combination of Geriatric Nutritional Risk Index and Carcinoembryonic Antigen to Predict the Survival of Patients With Colorectal Cancer.

Xie H, Wei L, Yuan G, Liu M, Liang Y, Gao S Front Nutr. 2022; 9:902080.

PMID: 35845803 PMC: 9280638. DOI: 10.3389/fnut.2022.902080.

References
1.
Li J, Xu R, Hu D, Zhang Y, Gong T, Wu X . Prognostic Nutritional Index Predicts Outcomes of Patients after Gastrectomy for Cancer: A Systematic Review and Meta-Analysis of Nonrandomized Studies. Nutr Cancer. 2019; 71(4):557-568. DOI: 10.1080/01635581.2019.1577986. View

2.
Noh G, Han J, Cho M, Hur H, Min B, Lee K . Impact of the prognostic nutritional index on the recovery and long-term oncologic outcome of patients with colorectal cancer. J Cancer Res Clin Oncol. 2017; 143(7):1235-1242. DOI: 10.1007/s00432-017-2366-x. View

3.
Chen L, Jiang B, Wang Z, Liu M, Yang H, Xing J . Combined preoperative CEA and CD44v6 improves prognostic value in patients with stage I and stage II colorectal cancer. Clin Transl Oncol. 2013; 16(3):285-92. DOI: 10.1007/s12094-013-1069-2. View

4.
Siegel R, Miller K, Jemal A . Cancer statistics, 2020. CA Cancer J Clin. 2020; 70(1):7-30. DOI: 10.3322/caac.21590. View

5.
Kang H, Seo S, Kim W, Yun S, Lee S, Kim W . Low preoperative serum cholesterol level is associated with aggressive pathologic features and poor cancer-specific survival in patients with surgically treated renal cell carcinoma. Int J Clin Oncol. 2017; 23(1):142-150. DOI: 10.1007/s10147-017-1172-4. View